TipRanks on MSN
Amgen’s New Prostate Cancer Study: A Potential Game-Changer?
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 1b clinical study ...
A randomized clinical trial published in JAMA Network Open has shown that electroacupuncture can significantly improve early ...
Clarity Pharmaceuticals Ltd. (($AU:CU6)) announced an update on their ongoing clinical study. Clarity Pharmaceuticals Ltd. is conducting a Phase 3 ...
Patients who underwent NeuroSAFE during nerve-sparing surgery showed improvement in erectile function at 12 months and urinary continence at 3 months. HealthDay News — Use of the NeuroSAFE technique, ...
For men with prostate cancer, radical prostatectomy, or surgical removal of the prostate, isn’t guaranteed to be curative, as one expert explained. Among men with prostate cancer, radical ...
Adding a surgery-specific module to a perioperative telemedicine programme significantly improved functional outcomes after radical prostatectomy, resulting in better urinary continence, a reduced ...
Darolutamide plus androgen-deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP) ...
Concerns have also been raised about the proportion of men who were only diagnosed after their disease had spread ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results